Press releases

Press releases

20 November 2014  - Paris (France)

Ipsen and CNRS create the "Archi-Pex" joint research and innovation lab, in collaboration with the University of Rennes 1 and CEA

18 November 2014  - Paris (France)

Ipsen and the Salk Institute renew their agreement for discovery research in medical sciences

06 November 2014  - Paris (France)

Otonomy obtains rights to gacyclidine data from Ipsen to support development of OTO-311 as a treatment for tinnitus

29 October 2014  - Paris (France)

Ipsen: sales in the 3rd quarter and first nine months of 2014

22 October 2014  - Paris (France)

Lexicon and Ipsen enter into ex-North America/Japan licensing and commercialization agreement for telotristat etiprate

10 October 2014  - Paris (France)

Ipsen announces positive results from phase III clinical study of Decapeptyl® (triptorelin pamoate) 11.25 mg administered by subcutaneous route to prostate cancer patients

10 October 2014  - Paris (France)

Aymeric Le Chatelier joins Ipsen as Executive Vice President, Chief Financial Officer

02 October 2014  - Paris (France)

Susheel Surpal steps down as Executive Vice President, Chief Financial Officer of Ipsen to pursue other opportunities

27 September 2014  - Paris (France)

Ipsen presents preliminary results of exploratory proof-of-concept study with tasquinimod in four advanced tumor types at the ESMO 2014 Congress

01 September 2014  - Paris (France)

Ipsen announces acceptance of filings for Somatuline® in the treatment of GEP-NETs in the US with priority review and in Europe